Shunts and the Pulmonary Vasculature

Prevalence of PAH in CHD              
Presented by David Celermajer
University of Sydney
celermajer-david
David Celermajer is the Head of the Discipline of Cardiology at the University of Sydney and Director of ACHD Services at the Royal Prince Alfred Hospital, where over 4000 ACHD patients are followed. An Editorial Board Member at Circulation, JACC, Heart and European Heart Journal, he has published over 400 papers in the international literature with an H-index of 90 and career citations over 40 000. His training was at the University of Sydney (where he won the University Medal), as a Rhodes Scholar in Oxford (studying the effects of alcohol on the heart using MRI!) and his PhD was from the University of London, in Childhood Origins of Atherosclerosis. His current interests include Early Detection of Pulmonary Vascular Disease and optimization of transition and later life care in ACHD.

 

Best Advice for Hemodynamic Assessment and  Interpretation in Patients with an ASD    
Presented by Rick Nishimura
Mayo Clinic

nishimura-rickDr. Nishimura is the Judd and Mary Morris Leighton Professor of Cardiovascular Diseases and Professor of Medicine at the Mayo Clinic College of Medicine.  He is a Master of the American College of Cardiology and Master of the American College of Physicians.  Dr. Nishimura’s research areas have involved the field of cardiovascular hemodynamics.  He has an active clinical practice with a particular interest in hypertrophic cardiomyopathy, valvular heart disease and pericardial disease.   He currently serves as Chair of the ACC/AHA Valvular Heart Disease Guideline Committee and has been on the ACC/AHA Parent Guideline Committee.  He has received the ACC Master Teacher Award, the American Heart Association Laennec Clinician/Educator Award, as well as the Mayo Clinic Distinguished Educator Award and the Mayo Clinic Distinguished Clinician Award.  He served as chair of education for the ACC in the past, was a member of the ACC Board  of Trustees, and was recently awarded the ACC Presidential Citation.

 

Pulmonary Vasoreactive Medications and Decisions about  Shunt Closure       
Presented by Elisa Bradley, MD
The Ohio State University

bradley-elisaDr. Elisa A. Bradley MD is an Assistant Professor of Medicine at The Ohio State University (Columbus, OH). She is a cardiologist and member of the Columbus Ohio Adult Congenital Heart (COACH) Program. She received her medical degree at the University of Illinois, completed Internal Medicine training at the University of Wisconsin, and general Cardiology fellowship at Washington University (St. Louis, MO). She then completed subspecialty adult congenital heart disease fellowship at The Ohio State University and Nationwide Children’s Hospital. Dr. Bradley’s research interests include: pulmonary hypertension in congenital heart disease, right ventricular function and failure, and Fontan associated liver disease.

 

QUERI ES and Lessons Learned Thus Far    
Presented by Curt Daniels
Nationwide Children’s Hospital.
Daniels pic
Curt J. Daniels, MD is a Professor of Clinical Internal Medicine and Pediatrics in the Division of Cardiology at The Ohio State University and the Division of Pediatric Cardiology at Nationwide Children’s Hospital. He is the Dottie Dohan Shepard Chair in Cardiovascular Medicine and the Director of the COACH program: Columbus Ohio Adult Congenital Heart Disease and Pulmonary Hypertension Program. Dr. Daniels is board certified in both pediatric cardiology and internal medicine cardiology. He serves on the Adult Congenital/Pediatric Cardiology Council and is the Co-Chair of the ACHD Working Group of the American College of Cardiology. In addition, Dr. Daniels serves as Chair of the Adult Congenital Heart Association Medical Advisory Board, and is Chair of the ACHA Program Accreditation Committee. Dr. Daniels is committed to education and has developed a fellowship training program for ACHD with over 10 fellow graduates, many of which have started new ACHD programs across the US. He has also worked to develop a subspecialty board certification in ACHD and currently serves as the Chair of the ABIM ACHD Subspecialty Board.  For the past 10 years Dr. Daniels has led a bi-monthly regional patient education lecture series for ACHD patients and has led the effort to provide a personalized electronic medical record for all patients followed in the ACHD program. Dr. Daniels has designed, implemented and successfully completed multiple ACHD research studies and presented his research nationally. In collaboration with colleagues from The Ohio State University and Nationwide Children’s Heart Center he has mentored fellows training thru the NIH T32 Training Grant entitled “Training in Congenital Heart Disease.” In 2011 Dr. Daniels was elected President of the International Society for ACHD with a focus on developing Global Health Initiatives for ACHD.  In 2014, he was selected as Co-Chair of the ACC/AHA ACHD Care Guidelines.

 

Disease Targeting Therapies in Eisenmenger Syndrome: Do They Make a Difference? If So, What Do They Do?
Presented by Alexander (Sasha) Opotowsky
Brigham and Women’s Hospital and Boston Children’s Hospital
opotowsky-sasha
Dr. Opotowsky is a staff member of the Boston Adult Congenital Heart (BACH) and Pulmonary Hypertension service at Brigham and Women’s Hospital and Boston Children’s Hospital, both in Boston. He completed medical school at Columbia University College of Physicians and Surgeons followed by training in Internal Medicine at Brigham and Women’s, adult Cardiology at the University of Pennsylvania, and an additional fellowship in pulmonary vascular disease and adult congenital heart disease with the BACH group. His research focuses on congenital heart                                          disease, exercise physiology, biomarkers and the pulmonary                                                circulation.

( average: 5.00 )
Loading...Loading...

Fontan Considerations I

Who Does Well and Why: Understanding Prognosis in Fontan.
Presented by Aleksander Kempny, MD
Barts Heart Centre, London, UK

kempny-aleksanderDr Aleksander Kempny is a Cardiologist for Adult Congenital Heart Disease at the Barts Heart Centre (formerly the Heart Hospital) in London, UK. He trained at the University Hospital in Muenster, Germany and at the Royal Brompton Hospital in London, UK. He is board certified in internal medicine, cardiology and echocardiography (ESC). His academic interest includes outcome analysis in patients with congenital heart disease as well as myocardial deformation analyses on echocardiography and MRI.  Dr Kempny’s main clinical interest includes management of patients with congenital heart disease, with particular focus on patients with coexisting pulmonary hypertension, patients with cyanotic lesions and Fontan circulation.

 

How Do We Define “Fontan Failure”?
Presented by Luke Burchill, MBBS PhD

burchill-lukeDr. Luke J Burchill MBBS PhD is an Assistant Professor of Medicine and Cardiologist in the Adult Congenital Heart Disease Program at the Knight Cardiovascular Research Institute, Oregon Health Science University (Portland, Oregon, USA). He received his medical degree and doctor of philosophy from the University of Melbourne (Melbourne, VIC, Australia) and subsequently completed postdoctoral fellowships in Adult Congenital Heart Disease (ACHD), Advanced Heart Failure & Heart Transplantation (Toronto General Hospital, ON, Canada), & Echocardiography (Cleveland Clinic, OH, USA). Dr. Burchill has made original contributions in the area of hormonal and genetic heart failure mechanisms, heart failure in ACHD, health care transitions for adolescents with ACHD, quality of life, and transplant outcomes in ACHD patients.

 

Latest Rationale and Data on Pulmonary Vascular Therapy in Fontan.
Presented by Jamil Aboulhosn, MD
Ahmanson/UCLA Adult Congenital Heart Disease Center

aboulhosn-jamilDr. Jamil Aboulhosn is the Director of the Ahmanson/UCLA Adult Congenital Heart Disease Center and an Associate Professor of Medicine and Pediatrics at UCLA.  He is also the Streisand/AHA endowed Chair in Cardiology.  He received his medical degree at the University of California Los Angeles and subsequently completed training in internal medicine, cardiovascular medicine at Harbor-UCLA followed by fellowships in adult congenital heart disease and congenital interventional cardiology at UCLA.  Dr. Aboulhosn has made numerous contributions in the areas of pulmonary hypertension, trans-catheter interventions and cardiovascular imaging.

 

“Double Double Coil and Trouble”: When and Why Should Collaterals Be Closed?
Presented by William Wilson, MBBS (Melb), FRACP
Royal Melbourne Hospital (Australia)

William WilsonWill completed general medicine and cardiology training at the Royal Melbourne Hospital, Australia. He undertook a fellowships in coronary intervention at the Royal Infirmary of Edinburgh (Scotland) and in adult congenital heart disease at the Toronto Congenital Cardiac Centre for Adults. He started as a consultant interventional cardiologist at the Royal Melbourne Hospital in 2014. He is currently undertaking a PhD at the University of Melbourne with a focus on adult congenital heart disease.


What Do We Do With the Liver? A Report from the “Fontan  and Liver Disease” ACC Consortium.

Presented by Curt Daniels, MD
Nationwide Children’s Hospital

daniels-curtCurt J. Daniels, MD is a Professor of Clinical Internal Medicine and Pediatrics in the Division of Cardiology at The Ohio State University and the Division of Pediatric Cardiology at Nationwide Children’s Hospital. He is the Dottie Dohan Shepard Chair in Cardiovascular Medicine and the Director of the COACH program: Columbus Ohio Adult Congenital Heart Disease and Pulmonary Hypertension Program. Dr. Daniels is board certified in both pediatric cardiology and internal medicine cardiology. He serves on the Adult Congenital/Pediatric Cardiology Council and is the Co-Chair of the ACHD Working Group of the American College of Cardiology. In addition, Dr. Daniels serves as Chair of the Adult Congenital Heart Association Medical Advisory Board, and is Chair of the ACHA Program Accreditation Committee. Dr. Daniels is committed to education and has developed a fellowship training program for ACHD with over 10 fellow graduates, many of which have started new ACHD programs across the US. He has also worked to develop a subspecialty board certification in ACHD and currently serves as the Chair of the ABIM ACHD Subspecialty Board.  For the past 10 years Dr. Daniels has led a bi-monthly regional patient education lecture series for ACHD patients and has led the effort to provide a personalized electronic medical record for all patients followed in the ACHD program. Dr. Daniels has designed, implemented and successfully completed multiple ACHD research studies and presented his research nationally. In collaboration with colleagues from The Ohio State University and Nationwide Children’s Heart Center he has mentored fellows training thru the NIH T32 Training Grant entitled “Training in Congenital Heart Disease.” In 2011 Dr. Daniels was elected President of the International Society for ACHD with a focus on developing Global Health Initiatives for ACHD.  In 2014, he was selected as Co-Chair of the ACC/AHA ACHD Care Guidelines.

(No Ratings Yet)
Loading...Loading...

The Systemic RV and What It Needs

Systematic RV Strain Imaging: Ready for Prime Time?  
Presented by William R Davidson, Jr. MD

DavidsonWilliam picWilliam R Davidson, Jr. MD is professor of Medicine in Cardiology at the Pennsylvania State University College of Medicine. He graduated from the University of Pennsylvania School of Medicine in 1979.  After finishing cardiology training at The University of Rochester he joined the cardiology faculty at the Penn State Hershey Medical Center in 1985 to serve as director of the echocardiography lab which he did from 1985 to 2014.  He founded the Program for Adult Congenital Heart Disease (PACHD) at Hershey in 1991 and still directs it. Has had a longstanding interest in the application of echocardiography to the diagnosis and management of adult congenital heart disease.  Was a contributor to the 32nd Bethesda Conference and has been active in the ACHA and ISACCD.

 

CRT for the Systemic RV? When and How?     
Presented by Stephen Seslar, MD

seslar-stephenDr. Steve Seslar is co-director of the UW Adult Congenital Electrophysiology Program and a UW associate professor of pediatrics. In addition to general cardiology, he is an expert in heart rhythm disorders and electrophysiology procedures.
He helped create a national quality improvement registry of pediatric and congenital electrophysiology that will capture outcomes on ablation procedures in adult patients with congenital heart disease. He is currently working to create a simulator to make electrophysiology procedures safer and more effective in adults with complex congenital heart disease and associated heart rhythm disorders. He is also collaborating on a stem-cell research project to help prevent arrhythmias in hearts damaged by surgery or a heart attack.
Dr. Seslar earned his bachelor’s degree from the University of Michigan and his M.D. /Ph.D. from Georgetown University. He did his pediatric residence training at the University of California, San Diego (UCSD) followed by pediatric cardiology and electrophysiology fellowship at Boston Children’s Hospital. Following this Dr. Seslar was the director of the electrophysiology program at UCSD. After 4 years at this position, he moved to the UW in 2008 to direct the Adult Congenital Electrophysiology Program.

 


Arbs and the Systemic RV: What We Do with Our Patients  and Why. 

Presented by Barbara Mulder, MD
Academic Medical Center in Amsterdam, the Netherlands.

mulder-barbaraBarbara JM Mulder is Professor of Cardiology in the Academic Medical Center in Amsterdam, the Netherlands. In 2001 she initiated the national registry and DNA bank for congenital heart disease, named CONCOR ( CONgenital CORvitia), in which presently over 16.000 patients have been included. She chaired the European Heart Survey on congenital heart disease with 79 participating centers from 24 countries.. From 2010 until 2012 she was president of the International Society of Adult Congenital Cardiology, ISACHD. At present, she is the president of the                                                  Netherlands Society of Cardiology.

 

Mechanical Support for the Systemic RV.     
Presented by Joshua Hermsen, MD
The University of Washington

hermsen-joshAn Assistant Professor of Surgery in the division of Cardio-thoracic Surgery at The University of Washington. Dr.Joshua Hermsen is board certified in adult and congenital heart surgery and specialize in the operative care of adults with congenital heart disease.  Other areas of specific interest include heart transplantation, hypertrophic ardiomyopathy, and infectious endocarditis.

 

Emerging Features of the Hypoplastic Left Heart Cohort.    
Presented by William Wilson, MBBS (Melb), FRACP
Royal Melbourne Hospital (Australia)

William WilsonWill completed general medicine and cardiology training at the Royal Melbourne Hospital, Australia. He undertook a fellowships in coronary intervention at the Royal Infirmary of Edinburgh (Scotland) and in adult congenital heart disease at the Toronto Congenital Cardiac Centre for Adults. He started as a consultant interventional cardiologist at the Royal Melbourne Hospital in 2014. He is currently undertaking a PhD at the University of Melbourne with a focus on adult congenital heart disease.

(No Ratings Yet)
Loading...Loading...

Contemporary Research and Oral Abstracts

The 10 Most Important ACHD Research Publications in the Past 2 Years
Presented by Gary Webb, MD

webb-gary pic

Gary D. Webb, M.D. is a Professor of Pediatrics and Internal Medicine at the University of Cincinnati College of Medicine and, until May 2016, the Director of the Adult Congenital Heart Program at Cincinnati Children’s Hospital Heart Institute. After receiving a BSC and MDCM from McGill University in Montréal Québec, he went on to intern at the Royal Victoria Hospital in Montréal, and then to training in internal medicine and cardiology at the University of Toronto. After 8 years as chief of cardiology at the Wellesley Hospital in Toronto, he moved back to Toronto General Hospital. Beginning in 1980, he was codirector and then director of the Toronto Congenital Cardiac Center for Adults. For several years, he directed the adult cardiology training program at the University of Toronto. He is a Fellow of the Royal College of Physicians and Surgeons of Canada in both internal medicine and cardiology. He is a Fellow of the American College of Cardiology, and a life member of the European Society of Cardiology. In 2004, he relocated to Philadelphia, serving as director of the Philadelphia Adult Congenital Heart Center at the University of Pennsylvania. In 2009, he took up his position at Cincinnati Children’s Hospital.

 

Vascular Abnormalities in the Fontan Circulation:  Histomorphometric Changes in the Central Arteries and Veins      
Presented by Brandon Hayes MD
Cincinnati Children’s Hospital Medical Center
hays-brandon
Dr. Hays is a practicing pediatric cardiologist with Pediatric Cardiology Associates of Houston. He completed medical school at Columbia University College of Physicians and Surgeons followed by training in Pediatrics at the University of Minnesota and a fellowship in Pediatric Cardiology at Cincinnati Children’s Hospital Medical Center, where he was the Chief Fellow from 2015-2016.  His research focus during fellowship focused on the Fontan circulation, a palliation of single ventricle heart disease as well as exercise physiology and the pulmonary circulation. Dr. Hays’ research was recently selected as the winner of the American Academy of Pediatrics Young Investigator Award for Fellows-in-training.


Contraceptive Practices of Women with Complex Congenital         

Presented by  Pamela D. Miner, RN, MN, NP
Ahmanson/UCLA Adult Congenital Heart Disease Center

pamela-miner1Pamela Miner has been a nurse practitioner for the Ahmanson/UCLA Adult Congenital Heart Disease Center since 1991.  She was on the writing committee for the 2008 ACC/AHA Guidelines for Management of Adults with Congenital Heart Disease, and was one of the founding members of the Adult Congenital Cardiac Care Associates Research Network (an international multi-center ACHD research group for non-physicians).  She has been a medical advisory board member for the Adult Congenital Heart Association since its inception.  She has lectured to both nursing and physician audiences across the U.S. and internationally.   Her areas of clinical interest are in long-term clinical outcomes in postoperative complex congenital heart disease, in management of cyanotic congenital heart disease, and in the aging patient with CHD.  Her current research focuses on Contraceptive Practices in Women with Congenital Heart Disease.

 

Heart Disease: A Multi-Center North American Experience Hepatocellular Carcinoma after the Fontan Operation: A Multicenter Case Series.     
Joseph Poterucha, MD

 

Performance of Guideline Indications for ICD Implantation in Adults with Congenital Heart Disease.
Jim Vehmeijer, MD

(No Ratings Yet)
Loading...Loading...

Perioperative ACHD

Prehabilitation–How to Make Surgery Safer
Presented by Luke Burchill MBBS PhD

burchill-lukeDr. Luke J Burchill MBBS PhD is an Assistant Professor of Medicine and Cardiologist in the Adult Congenital Heart Disease Program at the Knight Cardiovascular Research Institute, Oregon Health Science University (Portland, Oregon, USA). He received his medical degree and doctor of philosophy from the University of Melbourne (Melbourne, VIC, Australia) and subsequently completed postdoctoral fellowships in Adult Congenital Heart Disease (ACHD), Advanced Heart Failure & Heart Transplantation (Toronto General Hospital, ON, Canada), & Echocardiography (Cleveland Clinic, OH, USA). Dr. Burchill has made original contributions in the area of hormonal and genetic heart failure mechanisms, heart failure in ACHD, health care transitions for adolescents with ACHD, quality of life, and transplant outcomes in ACHD patients.

 

Cardiac Congenital Surgery and Short Term Mortality in the United Kingdom
Presented by Aleksander Kempny, MD

kempny-aleksanderDr. Aleksander Kempny is a Cardiologist for Adult Congenital Heart Disease at the Barts Heart Centre (formerly the Heart Hospital) in London, UK. He trained at the University Hospital in Muenster, Germany and at the Royal Brompton Hospital in London, UK. He is board certified in internal medicine, cardiology and echocardiography (ESC). His academic interest includes outcome analysis in patients with congenital heart disease as well as myocardial deformation analyses on echocardiography and MRI.  Dr. Kempny’s main clinical interest includes management of patients with congenital heart disease, with particular focus on patients with coexisting pulmonary hypertension, patients with cyanotic lesions and Fontan circulation.

 

Anesthesia Perspective on Improving Surgical Outcomes
Bryan Maxwell, MD, MPH
Randall Hospital Portland Oregon

maxwell hopkins headshotBryan G. Maxwell, MD, MPH is an anesthesiologist with the Oregon Anesthesiology Group in Portland, Oregon, and is Medical Director for Cardiac Anesthesiology for Legacy Emanuel Medical Center and Randall Children’s Hospital.  He is a full-time clinician and provides care for adult and pediatric cardiac populations, but has a particular interest in the care of adults with congenital heart disease (ACHD).

 

Hybrid Hype or Necessity? What Does a Combined Surgical/ Interventional Lab Offer in ACHD?
Thomas K. Jones, MD
University of Washington School of Medicine 

jones-thomasA Professor of Pediatrics and Adjunct Professor of Medicine at the University of Washington School of Medicine and the Director of the Cardiac Catheterization Laboratories at Seattle Children’s Hospital.  Dr. Jones is a graduate of the Jefferson Medical College in Philadelphia.  After completing his pediatrics residency at the University of Washington and his pediatric cardiology fellowship training at the University of Colorado and the Denver Children’s Hospital, Dr. Jones returned to Seattle where he spent the first 8 years of his career in private practice.  In 1991 Dr. Jones helped create the Children’s Heart Center at the Seattle Children’s Hospital.  In the same year he joined the academic faculty of the University of Washington and became the first Director of the Cardiac Catheterization Laboratories at the Seattle Children’s Hospital.

Dr. Jones’ lifelong work has focused on congenital and structural interventional cardiac catheterization in children and adults.  He has worked to pioneer several less invasive techniques to correct congenital heart conditions.  He has authored over 100 manuscripts, book chapters, and editorials and has participated as an investigator in over 30 multi-center clinical trials in the U.S.  Dr. Jones collaborates with emerging technology companies to develop and test new products designed to treat congenital and structural heart conditions. His research interests are currently focused on percutaneous heart valve implantation.  He continues to serve on national committees and task forces promoting clinical guidelines and practice standards for patients with congenital heart disease. He is collaborates with the FDA on novel approval pathways to improve patient access to more effective cardiovascular devices needed to treat the uncommon conditions that congenital cardiologists face every day.


What the Airline Industry Can Teach Us about Surgical Teams

Edward Hickey
The Hospital for Sick Children Toronto

(No Ratings Yet)
Loading...Loading...